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Cell-mediated cytolysis (CMC) of male, H-Y positive cell, by female effector cells, is subject to H-2 restriction (1). Furthermore, skin graft rejection caused by H-Y incompatibility is influenced by the H-2 type of both the male donor and the female recipient (2, 3) . These facts led Ohno to surmise that the H-2-Fl2M complex might act as an anchorage site for H-Y at the cell surface (4) (6) , H-2 (7), and HLA (6) have not resolved the question whether H-Y and H-2 are in fact physically associated, and we have sought further evidence of the contiguity of H-Y and H-2 by determining whether H-2 antiserum can inhibit lysis of male target cells by female effector cells in CMC assays (abbreviated as H-Y CMC). We looked especially for possible differences in inhibition by H-2D as compared with H-2K antibody because in mice of the strain we studied, C57BL/6 (B6), efficiency of H-Y CMC depends on compatibility of target and effector cells for D but not for K.
Materials and Methods
Mice. C57BL/6 (B6) mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. All other mice were obtained from E. A. Boyse at this Institute.
CMC Assay. The 5ZCr-release CMC assay was performed essentially according to Gordon and Simpson (8) .
Target Cells (T).
B6 male spleen cells were cultured for 5 d in RPMI (Grand Island Biological Co., Grand Island, N.Y.) supplemented with fetal calf serum (15%), glutamine (2 mM), 2-mercaptoethanol (5 × 10 -5 raM), penicillin, and streptomycin; concanavalin A (4 #g/ ml) was added on the 3rd d of culture. The cells were then washed once, labeled with 51Cr and suspended at a concentration of 1 × 105 cells/ml for the CMC assay (8) .
Effector Cells (E). B6 females, 2-3 mo old, were inoculated with 1 × 107 B6 male spleen cells intraperitoneally. Spleen cells were harvested 1-8 wk later, cocultured for 5 d in RPMI (supplemented as above) with irradiated B6 male spleen cells as described (8) , and suspended at a concentration of 2-15 × 10 s cells/ml for use in the CMC assay.
Assay. Equal volumes (50/~1 of target cells and effector cells) were placed in microtiter wells and incubated in 5% CO2 at 37°C for 4 h on a rocking platform. The supernates were harvested by the Titertek apparatus (Flow Laboratories, Inc., Roekville, Md.) and tested for 51Cr-release in a gamma counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Each test was set up in triplicate. Results are expressed as: specific 5ZCr release percent --100(A-B)/(C-B); where A = epm test sample; B = cpm spontaneous release with no effeetor cell; and C ----cpm maximal release (addition of 50/~1 of 1N HCL). Antisera. See Table I . Fig. 1 shows the effect produced by adding to the H-Y CMC assay the antisera specified in Table I . Addition of antiserum to D-region H-2 antigen (a-D b) inhibited lysis significantly at an assay dilution of 1:80 and almost completely at 1:20. The addition of K-region H-2 antibody (a-K b) did not inhibit lysis and titers of these antisera in cytotoxicity assays were similar. Lysis was not inhibited by NMS, nor by the control antiserum, H-2 b anti-H-2 d, which could not react specifically with the cells, which were H-2 b (B6). Other antisera, such as a-Thy-l.2 and a-Ly-2.2 at the same dilutions, had no inhibitory effect (data not shown).
Results

Blocking of H-Y CMC by Antibody to D-region H-2 Antibody.
Specificity of Inhibition of H-Y CMC by D-region H-2 Antibody.
To further test the antigenic specificity of inhibition of H-Y CMC by D b antibody, two portions of a-D b serum were absorbed, one with BALB.G and the other with BALB male spleen and lymph node cells. The H-2 haplotype of BALB.G is H-2 g, a recombinant between H-2 d (BALB) and H-2 b (C57BL) (9) . Thus, BALB and BALB.G differ in the D-region of H-2 but are similar in the region I to K inclusive. Absorption of c~-D b serum with BALB.G, but not with BALB, abolished its capacity to inhibit H-Y CMC (Fig. 2) . that such adjustments in the display of surface molecules are serological artifacts. We propose that H-Y and H-2D b normally are not closely adjacent, but become so in response to activators. The question whether this change in configuration of the target cell surface is an incidental or necessary event in H-Y-specific CMC cannot be answered at the present time.
SERUM DILUTION
Fla. 2. Specificity of inhibition by D-region H-2 antibody: tests with ot-D h serum absorbed with BALB.G or BALB male cells. Each point is the mean of readings from two separate tests (E:T = 15:1).
Time Dependency of the Blocking of H-Y CMC by
Summary
Assays of H-Y-specific cell-mediated cytolysis (CMC) in vitro were carried out with B6 female effector cells and B6 male target cells. This lytic system depends on compatibility for H-2D b but not for H-2K b. Antibody to H-2D b but not to H-2K ~ blocked the CMC assay. However, maximal blocking required exposure of the target cells to H-2D b antibody for up to 2 h. This interval is far longer than would be required for blocking of a pre-existing H-Y:H-2D b complex, and seems more consonant with a membrane reorganization bringing H-Y and H-2D b together, as proposed from mapping studies. The question whether the postulated configurational change affecting H-Y and H-2D b is a necessary feature of CMC awaits further study.
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